"Designing Growth Strategies is in our DNA"
Stress test equipment measures the ability of the heart to respond to external stress in a controlled, clinical environment. Stress tests enable the healthcare provider or physician to identify anomalies such as insufficient oxygen supply to the heart, and abnormal blood flow in stressful conditions. These tests are often performed using specialized exercise equipment such as a bicycle, treadmill, or ergometer. An Electrocardiogram (ECG) machine is attached to the patient along with other equipment to carry out this test. These tests are also recommended for patients with cardiovascular disorders, such as irregular heartbeat, chest pain, or difficulty breathing.
Some factors driving the growth of the market include aging population, and growing awareness about various cardiac and pulmonary diseases, among the general population. Moreover, a sedentary lifestyle is a critical factor contributing to the increasing prevalence of cardiovascular and respiratory disease. Hence, this will increase the diagnosis rate of the patient population undergoing stress tests for the detection of chronic diseases.
Also, market players are focusing on catering to this rising demand by introducing novel equipment with advanced technology. However, the lack of uniformity about the reimbursement policies for stress test equipment in various regionals may slower the market growth.
The outbreak of the COVID-19 pandemic has impacted the global market negatively. The pandemic challenged stress resilience and mental health outcomes among specific vulnerable population groups such as patients with a psychiatric disorder, COVID-19-diagnosed patients, healthcare workers, children and adolescents, pregnant women, and elderly people. The early stages of the Covid-19 pandemic were often associated with increased levels of distress, depression, and anxiety symptoms in the general population.
The stress level among the population increased during the pandemic, but people could not visit healthcare settings to take stress tests due to lockdown restrictions. Hence, the utilization of stress test equipment during the pandemic declined, leading to slower market growth.
The market is expected to recover and exhibit the pre-pandemic growth level in terms of patient visits. It is anticipated to grow at a pre-pandemic growth rate during the forecast period 2023-2030.
Based on the product, the market is segmented into bench-top, trolley-mounted, and wearable devices. The trolley-mounted is expected to account for a significant share of the global market, owing to the ease of handling and technological advancements these products offer. However, wearable devices are expected to drive market growth during the forecast period due to increasing preference for these products among the general population.
To gain extensive insights into the market, Download for Customization
Among regions, North America is expected to dominate the global stress test equipment market during the forecast period. The factors attributing to dominance are the rising incidence of cardiovascular and respiratory diseases coupled with developed healthcare infrastructure to meet the increasing demand for advanced diagnosis products among the region's general population. According to the Centers for Disease Control and Prevention (CDC) 2020 data, Coronary heart disease (CHD) is the most common type of heart disease that is killing approximately 382,820 people annually.
One of the major causes contributing to the increased number of heart diseases is stress. As the awareness related to stress diagnosis tests will rise, the adoption rate of these products across the region will lead to regional growth.
The report will include the profiles of key players such as Advanced Instrumentations, GE Healthcare, SCHILLER AG, Clarity Medical, Spacelabs Healthcare, Koninklijke Philips N.V., Glen Med Solutions, MGC DIAGNOSTICS CORPORATION, Mortara Instruments, Inc., and others.
|
By Technology |
By Product |
By End User |
By Geography |
|
|
|
|
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )